基于随机森林算法的脂肪肝健康分级管理平台构建探索

Construction of a fatty liver health grading management platform based on random forest algorithm

摘要

针对当前脂肪肝分级管理中存在的方法单一、个性化不足等问题,本文设计了一种基于机器学习方法的脂肪肝健康分级管理平台。该平台采用模块化、可扩展的系统架构,整合医疗知识与信息技术,实现对脂肪肝风险的智能分级与精准评估。平台功能涵盖了健康管理、就医服务、个性化服务、信息总览等多个方面,为患者提供了全方位的健康管理服务。基于医院患者数据,利用随机森林算法进行风险分级筛选,有效提升了数据处理效率与早期识别能力。统计分析功能对患者数据进行深入挖掘,为临床决策与健康管理提供了科学依据。实际应用结果表明,该平台能够早期发现脂肪肝患者并支持及时干预。个性化服务提高患者的就医体验和治疗效果,为医疗行业的数字化转型和智能化升级提供了有益借鉴。

Abstract

This paper introduces the design of a fatty liver health grading management platform based on machine learning methods. Aiming at the shortcomings of the current fatty liver grading management field, the platform integrates advanced information technology and medical knowledge to provide comprehensive, efficient and personalized health management services for fatty liver patients. The platform architecture design adopts a modular and scalable design approach to ensure the stability and maintainability of the system. The random forest algorithm is used to perform AI grading screening of hospital patient data, which can improve the efficiency of data processing and realize the accurate assessment of fatty liver risk. The platform's functions cover health management, medical services, personalized services, information overview and other aspects, providing patients with a full range of health management services. The function of statistical analysis enables in-depth mining and analysis of patient data, and also provides a scientific and reliable decision-making support basis for subsequent health management. The platform has achieved remarkable results in practical applications. By using the random forest algorithm for grading screening, the platform can detect fatty liver patients early and provide them with timely intervention and treatment. The tailor-made service has been well received by patients, in that it improves their medical experience and treatment effects. The platform provides not only better health management services for patients with fatty liver but also useful exploration and reference for the digital transformation and intelligent upgrading of the medical industry.

关键词

分级管理平台 / 随机森林算法 / 脂肪肝 / 健康管理

Key words

hierarchical management platform / random forest algorithm / fatty liver / health management

参考文献

[1] 孙萌, 罗芳琼, 兰梦, 等 . 超声脂肪分数定量评估肥胖人群肝脏脂肪变性的临床价值[J]. 临床超声医学杂志, 2024, 26(9): 719-723.

[2] SUN M, LUO F Q, LAN M, et al. Clinical value of ultrasound—derived fat fraction in the quantitative assessment of hepatic steatosis in obese population[J]. J Clini Ultrasound Med, 2024, 26(9): 719-723.

[3] 华绪文, 方敏, 尤吴溢, 等 . 磁共振FACT序列在非酒精性脂肪肝诊断中的准确性分析[J]. 临床放射学杂志, 2025, 44(6): 1030-1034.

[4] HUA X W, FANG M, YOU W Y, et al. Accuracy analysis of magnetic resonance FACT sequence in the diagnosis of nonalcoholic fatty liver disease[J]. J Clini Radiol, 2025, 44(6): 1030-1034.

[5] 窦紫岩, 钱文红, 孔邻润, 等 . 非酒精性脂肪性肝病检出率现状及其影响因素: 基于北京市32万人群数据[J]. 中国全科医学, 2024, 27(2): 144—149, 155.

[6] DOU Z Y, QIAN W H, KONG L R, et al. Detection rate of non—alcoholic fatty liver disease and its influencing factors: analysis based on the data of 320 000 Beijing population[J]. Chin Gen Pract, 2024, 27(2): 144—149, 155.

[7] 刘莉, 张克俊, 刘佳鑫 . 紧密型县域医共体建设和乡村健康治理绩效提升:作用机制与依存条件———基于3个典型县的跨案例分析[J]. 中国卫生事业管理, 2025, 42(10): 1081—1087, 1108.

[8] LIU L, ZHANG K J, LIU J X. Study on the tight county medical consortium construction and rural health governance performance improvement from its mechanisms and enabling conditions based on a cross—case analysis in three typical counties[J]. Chin Health Serv Manag, 2025, 42(10): 1081—1087, 1108.

[9] 刘欣奕, 范鹏超, 刘文芝 . 人工智能技术在医院感染管理中的应用与研究进展[J]. 中国感染控制杂志, 2025, 24(11): 1671-1680.

[10] LIU X Y, FAN P C, LIU W Z. Application and research progress of artificial intelligence technology in healthcare—associated infection management[J]. Chin J Infect Control, 2025, 24(11): 1671-1680.

[11] 谢理哲, 严斌, 王林 . 人工智能在口腔医学中的应用[J]. 首都医科大学学报, 2025, 46(6): 968-976.

[12] XIE L Z, YAN B, WANG L. The application of artificial intelligence in stomatology[J]. J Cap Med Univ, 2025, 46(6): 968-976.

[13] LI H, LIU H, HU D, et al. Promise: prompt—driven 3D medical image segmentation using pretrained image foundation models[C]//2024 IEEE International Symposium on Biomedical Imaging (ISBI). Athens, Greece: IEEE, 2023: 1-5.

[14] 郑仁阔, 华飞 . 代谢相关脂肪性肝病与甲状腺乳头状癌的相关性研究[J]. 中国全科医学, 2025, 29(15): 2029-2036.

[15] ZHENG R K, HUA F. The correlation between metabolic dysfunction—associated steatotic liver disease and papillary thyroid carcinoma[J]. Chin Gen Pract, 2025, 29(15): 2029-2036.

[16] 崔立真, 孙晓芳, 刘宁, 等 . 多源异构医疗大数据融合与分析技术[J]. 山东大学学报(工学版), 2026, 56(1): 1-13.

[17] CUI L Z, SUN X F, LIU N, et al. Multi—source heterogeneous healthcare big data fusion and analysis technology[J/OL].J Shandong Univ (Eng Sci), 2026, 56(1): 1-13.

[18] 侯树辰, 许凤全, 胡理, 等 . 基于机器学习算法的抑郁症与双相情感障碍预测模型研究进展[J/OL].科学通报, 2025: 1-11 (2025—11—27) [2025—11—30].https://link.cnki.net/urlid/11.1784.N.20251126.1149.020.

[19] HOU S C, XU F Q, HU L, et al. Research progress in prediction models of depression and bipolar disorder based on machine learning algorithms[J/OL].Chin Sci Bull, 2025: 1-11 (2025—11—27) [2025—11—30].https://link.cnki.net/urlid/11.1784.N.20251126.1149.020.

[20] 吕珂 . 人工智能在超声检查肝脏疾病中的应用: 现状、挑战及展望[J]. 中国医学影像技术, 2025, 41(8): 1327-1332.

[21] LV K. Application of artificial intelligence ultrasound imaging of liver diseases: current status, challenges and prospects[J]. Chin J Med Imaging Technol, 2025, 41(8): 1327-1332.

[22] 吴小玉, 石璐, 受梦媛, 等 . 1990—2021年中国非酒精性脂肪性肝病疾病负担变化和2020—2040年中国NAFLD疾病负担预测研究[J]. 实用肝脏病杂志, 2025, 28(5): 707-710.

[23] WU X Y, SHI L, SHOU M Y, et al. 1990—2021 disease burden of non—alcoholic fatty liver disease in China and its trends from 2020 to 2040[J]. Journal of Practical Hepatology, 2025, 28(5): 707-710.

[24] 陈文佳, 石静, 李悦, 等 . 人工智能赋能:解锁心血管代谢性疾病防控新途径[J]. 中国实用内科杂志, 2025, 45(11): 893-898.

[25] CHEN W J, SHI J, LI Y, et al. AI for cardiometabolic health: novel strategies for prevention and care[J]. Chinese Journal of Practical Internal Medicine, 2025, 45(11): 893-898.

[26] 彭玉姣, 黄晶晶, 吴颖升, 等 . 基于NHANES 2011—2014数据分析握力相关恶病质指数与肝功能异常人群全因死亡相关性研究[J]. 现代检验医学杂志, 2025, 40(6): 137-141, 170.

[27] PENG Y J, HUANG J J, WU Y S, et al. Study on the correlation between hand grip strength—based cachexia index and all—cause mortality in a population with abnormal liver function based on NHANES 2011—2014 data[J]. Journal of Modern Laboratory Medicine, 2025, 40(6): 137-141, 170.

[28] 姜梦秋, 郑红星, 聂旭莲, 等 . 低GI膳食对代谢性疾病的干预作用研究进展[J]. 粮油食品科技, 2025, 33(6): 107-117.

[29] JIANG M Q, ZHENG H X, NIE X L, et al. Research progress on the intervention effect of low glycemic index diet on metabolic diseases[J/OL].Sci Technol Cereals Oils Foods, 2025, 33(6): 107-117.

[30] 李蕊, 沙立云, 衡友官, 等 . 运动调控肠道菌群及代谢物改善代谢相关脂肪性肝病的研究进展[J/OL].生命科学, 2025: 1-14 (2025—09—19) [2025—11—30].https://link.cnki.net/urlid/31.1600.q.20250918.1937.002.

[31] LI R, SHA L Y, HENG Y G, et al. Research progress on exercise regulation of gut microbiota and metabolites in improving metabolic—associated fatty liver disease[J]. Chin Bull Life Sci, 2025: 1-14(2025—09—19) [2025—11—30].https://link.cnki.net/urlid/31.1600.q.20250918.1937.002.

基金资助

西安交通大学第一附属医院2022年院级教学改革研究项目(JG2022-0321)